Skip to main content
. Author manuscript; available in PMC: 2021 Mar 6.
Published in final edited form as: Leukemia. 2020 Jun 18;35(3):850–862. doi: 10.1038/s41375-020-0922-x

Figure 4. Chimerism patterns after haplo-dCBT in patients with a transient myeloid bridge (Group 2, n = 20).

Figure 4.

Whole blood chimerism analysis (Figure 4A) revealed short-lived haplo-identical donor engraftment (median day 14 haplo-identical donor chimerism 82%, range 0–100%) followed by sustained CB-derived hematopoiesis. Both myeloid (Figure 4B) and T-cell (Figure 4C) lineages were primarily derived from the dominant CB unit as early as day 28.

*Footnote: Red: Haplo-identical donor; Blue: Dominant (engrafting) CB unit; Green: Non-dominant (non-engrafting) unit